|
| |
| | | 68178 | | 05.11.2020 | | Takeda Pharma AG | | | | | | | | | | | | | 02.99. | | | | 02.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | TAKHZYRO 300 mg | Injektionslösung in einer Fertigspritze | Injection solution in prefilled syringe (Lanadelumabum 300mg / 2ml) | B06AC05 | CI | | 02 | TAKHZYRO 150 mg | Injektionslösung in einer Fertigspritze | Injection solution in prefilled syringe (Lanadelumabum 150 mg/ml) | B06AC05 | CI |
|
|
|
